Lymphomas and Lymphoproliferative Disorders: From Diagnosis to Treatment

Dear Colleagues,

The diagnosis and treatment of lymphoma has been significantly advanced by the appearance of biomarkers and molecular targeted drugs. Lymphoproliferative disorders consist of a wide spectrum between polyclonal and monoclonal lymphoid proliferation, i.e., including benign lymphoid lesions to lymphomas. Lymphoproliferative disorders, benign lymphoid lesions in particular, and their etiology and pathogenesis are still unknown, and pathological diagnosis has not been established in many disorders.

This Topic will highlight recent advances and knowledge acquired in lymphomas and lymphoproliferative disorders aspects of clinical and pathological findings, pathogenesis, as well as treatment strategy. Research revealing negative results is also welcome. We seek expert research articles, review articles, and case reports on recent advances in lymphomas and lymphoproliferative disorders, including future perspectives/directions.

Prof. Dr. Yasuharu Sato
Dr. Midori Filiz Nishimura
Dr. Yoshito Nishimura
Topic Editors